We are live on ! Find out more
MAP

Madison Avenue Partners Portfolio holdings

AUM $2.3B
1-Year Est. Return 115.82%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+115.82%
3 Year Est. Return
+241.12%
5 Year Est. Return
+319.41%
10 Year Est. Return
AUM
$705M
AUM Growth
+$246M
Cap. Flow
+$200M
Cap. Flow %
28.34%
Top 10 Hldgs %
95.7%
Holding
24
New
5
Increased
5
Reduced
4
Closed
4

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$20.8M
2
GIII icon
G-III Apparel Group
GIII
+$15.5M
3
MBC icon
MasterBrand
MBC
+$15.1M
4
ONL
Orion Office REIT
ONL
+$3.61M
5
SLVM icon
Sylvamo
SLVM
+$1.62M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 51.49%
2 Industrials 20.4%
3 Healthcare 19.16%
4 Communication Services 4.76%
5 Real Estate 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SN icon
1
SharkNinja
SN
$21B
$283M 40.21%
+6,112,191
New +$224M
GHC icon
2
Graham Holdings Company
GHC
$4.97B
$122M 17.32%
209,401
+8,917
+4% +$5.17M
GIII icon
3
G-III Apparel Group
GIII
$1.47B
$79.5M 11.28%
3,188,997
-725,872
-19% -$15.5M
TBPH icon
4
Theravance Biopharma
TBPH
$874M
$60.5M 8.59%
7,012,226
IART icon
5
Integra LifeSciences
IART
$1.54B
$36.8M 5.23%
964,667
+40,000
+4% +$1.68M
STGW icon
6
Stagwell
STGW
$1.84B
$33.5M 4.76%
7,147,662
PFSW
7
DELISTED
PFSweb, Inc.
PFSW
$19.6M 2.78%
2,633,189
ONL
8
Orion Office REIT
ONL
$148M
$18.2M 2.59%
3,501,281
-594,620
-15% -$3.61M
OVID icon
9
Ovid Therapeutics
OVID
$435M
$14M 1.99%
3,648,509
+340,904
+10% +$1.23M
MACK
10
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$6.82M 0.97%
553,085
FSP
11
Franklin Street Properties
FSP
$44.8M
$6.09M 0.86%
3,291,443
+1,288,790
+64% +$2.29M
TSVT
12
DELISTED
2seventy bio
TSVT
$5.86M 0.83%
+1,494,125
New +$9.8M
GOSS icon
13
Gossamer Bio
GOSS
$66.5M
$5.11M 0.72%
+6,130,268
New +$7.06M
RNAC icon
14
Cartesian Therapeutics
RNAC
$232M
$4.25M 0.6%
+133,601
New +$4.46M
MBI icon
15
MBIA
MBI
$288M
$3.03M 0.43%
420,826
VSTS icon
16
Vestis
VSTS
$2.06B
$2.12M 0.3%
+110,000
New +$2.13M
CEE
17
Central and Eastern Europe Fund
CEE
$135M
$1.81M 0.26%
211,030
INDV icon
18
Indivior Pharmaceuticals
INDV
$4.79B
$902K 0.13%
39,087
+27,887
+249% +$636K
LNSR icon
19
LENSAR
LNSR
$68.8M
$743K 0.11%
240,341
-117,122
-33% -$401K
SFE
20
DELISTED
Safeguard Scientifics, Inc.
SFE
$359K 0.05%
359,085
-32,374
-8% -$42.1K
FHN icon
21
First Horizon
FHN
$12.1B
-1,843,065
Closed -$20.8M
JRVR icon
22
James River Group Holdings
JRVR
$218M
-63,887
Closed -$1.17M
MBC icon
23
MasterBrand
MBC
$1.09B
-1,298,688
Closed -$15.1M
SLVM icon
24
Sylvamo
SLVM
$1.52B
-40,163
Closed -$1.62M

Similar funds

Madison Avenue Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Madison Avenue Partners held 24 positions worth $705M, up 54% from $458M the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Madison Avenue Partners deployed $200M of net new capital in Q3 2023, opening 5 new positions and adding to 5 existing holdings. Its largest new stake was SharkNinja: 6,112,191 shares worth $283M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 51% of assets, up from 20% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was G-III Apparel Group, an estimated $15.5M trimmed.

  • Madison Avenue Partners's largest Q3 2023 buy was SharkNinja: 6,112,191 shares worth $283M.
  • Madison Avenue Partners added most to Graham Holdings Company in Q3 2023, an estimated $5.17M increase.
  • Madison Avenue Partners's biggest Q3 2023 reduction was G-III Apparel Group, cutting an estimated $15.5M.
  • Madison Avenue Partners fully exited First Horizon in Q3 2023, selling an estimated $20.8M.
  • Madison Avenue Partners's ten largest holdings make up 96% of its $705M portfolio in Q3 2023.
  • Madison Avenue Partners opened 5 new positions and closed 4 in Q3 2023.
  • Madison Avenue Partners's portfolio value rose 54% quarter-over-quarter to $705M.

Based on Madison Avenue Partners's 13F filing for Q3 2023, filed 14 Nov 2023.